QIAGEN and Applied Biosystems Settle All Disputes Over Real-Time PCR Thermal Cycler Patents

VENLO, The Netherlands, Jan. 22, 2009 (GLOBE NEWSWIRE) -- Corbett, QIAGEN (Nasdaq:QGEN) (Frankfurt:QIA), ltf Labortechnik GmbH & Co. KG, and Applied Biosystems, LLC, part of Life Technologies Corporation (Nasdaq:LIFE) today announced a settlement of their disputes concerning infringement by Corbett’s Rotor-Gene(tm) Real-Time PCR-Cyclers and Applied Biosystems’ Real-Time Thermal Cycler Instrument patents. Applied Biosystems had filed an infringement lawsuit against Corbett in Germany and Corbett later filed a declaratory judgment lawsuit in California. Further, Corbett and ltf Labortechnik filed an intervention in opposition proceedings before the European Patent Office. QIAGEN acquired Corbett, an Australian instrumentation manufacturing company, in July 2008.

MORE ON THIS TOPIC